FierceBiotech 4. Juni 2026 As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
Endpoints News 4. Juni 2026 Novo Holdings backs European fund; Alnylam sends second obesity drug into clinic
Lonza News 4. Juni 2026 Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies - The Manila Times
Lonza News 4. Juni 2026 Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies - The Manila Times
FierceBiotech 4. Juni 2026 Innovent, fresh from $1.2B deal, posts phase 3 win for Takeda-partnered ADC
PharmaVoice 4. Juni 2026 Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?